Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
Matthew A PowellVirginia L FiliaciMartee L HensleyHelen Q HuangKathleen M MooreKrishnansu S TewariLarry J CopelandAngeles A SecordDavid G MutchAlessandro SantinDavid P WarshalNick M SpirtosPaul A DiSilvestroOlga B IoffeDavid Scott MillerPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
PC was not inferior to the active regimen PI and should be standard treatment for UCS.